Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
128 studies found for:    kaiser permanente and cancer | Open Studies
Show Display Options
Rank Status Study
1 Not yet recruiting Implementing Systematic Distress Screening in Breast Cancer
Condition: Breast Cancer
Intervention: Behavioral: Distress screening
2 Recruiting Strategies and Opportunities to Stop Colon Cancer in Priority Populations
Condition: Colorectal Cancer
Intervention: Other: Auto Plus
3 Recruiting Autologous Fat Grafting of the Breast in Women With Post Lumpectomy Contour Defects
Conditions: Cancer of the Breast;   Anomaly of Breast
Interventions: Procedure: Autologous Fat Grafting of the Breast;   Other: Control Arm
4 Recruiting Palliative Care Intervention in Improving Symptom Control and Quality of Life in Patients With Stage II-IV Non-small Cell Lung Cancer and Their Family Caregivers
Conditions: Caregiver;   Psychological Impact of Cancer and Its Treatment;   Recurrent Non-small Cell Lung Cancer;   Stage IIA Non-small Cell Lung Cancer;   Stage IIB Non-small Cell Lung Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer
Interventions: Other: Palliative Therapy;   Other: quality-of-life assessment;   Other: questionnaire administration
5 Not yet recruiting The Watch the Spot Trial
Conditions: Solitary Pulmonary Nodule;   Coin Lesion, Pulmonary;   Lung Neoplasms;   Carcinoma, Non-small-cell Lung
Interventions: Other: More Frequent Surveillance Strategy;   Other: Less Frequent Surveillance Strategy
6 Recruiting CATCH-UP Intervention in Increasing Cancer Screening and Prevention Care in Uninsured Patients at Community Health Centers
Conditions: Breast Carcinoma;   Cervical Carcinoma;   Colorectal Carcinoma;   Health Status Unknown;   Human Papillomavirus Infection;   Malignant Neoplasm
Intervention: Other: Informational Intervention
7 Recruiting Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma
Conditions: Glioma;   Glioblastoma
Intervention: Radiation: FDOPA PET/CT
8 Recruiting PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery
Condition: Colorectal Cancer
Interventions: Drug: FOLFOX (chemotherapy);   Other: 5 FUCMT (chemoradiation);   Procedure: surgery;   Procedure: magnetic resonance imaging or endorectal ultrasound
9 Recruiting Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy
Conditions: Stage II Breast Cancer;   Stage IIIA Breast Cancer
Interventions: Procedure: Axillary Lymph Node Dissection (ALND);   Radiation: Nodal Radiation Therapy;   Radiation: Axillary Radiation Therapy
10 Recruiting S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Condition: Breast Cancer
Interventions: Drug: anastrozole;   Drug: everolimus;   Drug: exemestane;   Drug: goserelin acetate;   Drug: letrozole;   Drug: leuprolide acetate;   Drug: tamoxifen citrate;   Other: placebo
11 Recruiting S1204, Viral Screening in Newly Diagnosed Cancer Patients
Condition: Cancer
Intervention:
12 Recruiting S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: TAK-700;   Drug: Bicalutamide
13 Recruiting S1200: Acupuncture, Sham Acupuncture, or Wait List for Joint Symptoms Related to Aromatase Inhibitors in Pts W/Early-Stage Breast Cancer
Conditions: Breast Cancer;   Pain
Interventions: Procedure: acupuncture therapy;   Procedure: sham acupuncture
14 Recruiting Breast Cancer WEight Loss Study (BWEL Study)
Conditions: Ductal Breast Carcinoma in Situ;   Breast Carcinoma
Interventions: Other: Health Education Program;   Other: Weight Loss Intervention
15 Recruiting Molecular Profiling in Tissue Samples From Patients With Cancer Who Are Exceptional Responders to Treatment
Condition: Malignant Neoplasm
Intervention: Other: Laboratory Biomarker Analysis
16 Recruiting Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
Condition: Lung Cancer
Interventions: Radiation: Standard Radiation Dose Therapy;   Drug: cisplatin;   Drug: etoposide;   Radiation: High Radiation Dose Therapy;   Drug: carboplatin
17 Recruiting FOLFIRI or Modified FOLFIRI and Veliparib as Second Line Therapy in Treating Patients With Metastatic Pancreatic Cancer
Conditions: Metastatic Pancreatic Adenocarcinoma;   Recurrent Pancreatic Carcinoma;   Stage IV Pancreatic Cancer
Interventions: Drug: Fluorouracil;   Drug: Irinotecan Hydrochloride;   Other: Laboratory Biomarker Analysis;   Drug: Leucovorin Calcium;   Drug: Veliparib
18 Recruiting Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer
Conditions: Breast Adenocarcinoma;   Estrogen Receptor Negative;   HER2/Neu Negative;   Progesterone Receptor Negative;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIC Breast Cancer;   Triple-Negative Breast Carcinoma
Interventions: Drug: Carboplatin;   Drug: Cyclophosphamide;   Drug: Doxorubicin Hydrochloride;   Other: Laboratory Biomarker Analysis;   Drug: Paclitaxel
19 Recruiting Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Conditions: Stage IB Non-Small Cell Lung Carcinoma;   Stage IIA Non-Small Cell Lung Carcinoma;   Stage IIB Non-Small Cell Lung Carcinoma;   Stage IIIA Non-Small Cell Lung Cancer
Interventions: Drug: Crizotinib;   Other: Laboratory Biomarker Analysis;   Other: Placebo
20 Recruiting Genetic Testing in Screening Patients With Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Conditions: Large Cell Lung Carcinoma;   Lung Adenocarcinoma;   Stage IB Non-Small Cell Lung Carcinoma;   Stage IB Squamous Cell Lung Carcinoma;   Stage IIA Non-Small Cell Lung Carcinoma;   Stage IIA Squamous Cell Lung Carcinoma;   Stage IIB Non-Small Cell Lung Carcinoma;   Stage IIB Squamous Cell Lung Carcinoma;   Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIA Squamous Cell Lung Carcinoma
Interventions: Other: Cytology Specimen Collection Procedure;   Other: Laboratory Biomarker Analysis

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.